More than a dozen pharmas have recently struck deals with the White House to lower drug prices. Nevertheless, drugmakers ...
Drugmakers hike prices 350 drugs in January, including Pfizer's COVID-19 vaccine and hospital drugs, with a median increase of 4%.
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains1 Shipping of the LP.8.1-adapted vaccine will ...
Pfizer Inc. (NYSE:PFE) is included among the 13 Best January Dividend Stocks to Invest in. Pfizer Inc. (NYSE:PFE) is among ...
Stocktwits on MSN
Pfizer leads new wave of 2026 US drug price hikes despite Trump’s drug cost crackdown: report
More medicines are slated for price hikes in 2026, with increases tracking around recent inflation levels. ・Only a few drugs ...
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
U.S. drugmakers are planning to raise prices on at least 350 branded prescription medications in 2026, including major ...
According to healthcare research firm 3 Axis Advisors, drugmakers are planning to raise U.S. prices on medications including ...
As 2026 begins, Pfizer is deploying a dual strategy of pharmaceutical price increases and targeted investor outreach. The market is watching closely to see if this year will mark the promised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback